These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3598569)

  • 21. Programme factors that influence completion of residential treatment.
    Meier PS; Best D
    Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State.
    Wickizer T; Maynard C; Atherly A; Frederick M; Koepsell T; Krupski A; Stark K
    Am J Public Health; 1994 Feb; 84(2):215-21. PubMed ID: 8296943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of centralized intake on outcomes of substance abuse treatment.
    Rohrer JE; Vaughan MS; Cadoret RJ; Carswell C; Patterson A; Zwick J
    Psychiatr Serv; 1996 Nov; 47(11):1233-8. PubMed ID: 8916242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Program Environment Scale: assessing client perceptions of community-based programs for the severely mentally ill.
    Burt MR; Duke AE; Hargreaves WA
    Am J Community Psychol; 1998 Dec; 26(6):853-79. PubMed ID: 10085535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives on adolescent residential substance abuse treatment: when are adolescents done?
    Wisdom JP; Gogel LP
    Psychiatr Serv; 2010 Aug; 61(8):817-21. PubMed ID: 20675841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family and client characteristics as predictors of outpatient treatment outcome for adolescent drug abusers.
    Friedman AS; Terras A; Kreisher C
    J Subst Abuse; 1995; 7(3):345-56. PubMed ID: 8749793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying strengths in youths at substance use treatment admission.
    Pagano ME; Raj NM; Rhodes C; Krentzman AR; Little M
    Am J Drug Alcohol Abuse; 2019; 45(4):410-420. PubMed ID: 31045452
    [No Abstract]   [Full Text] [Related]  

  • 30. How important are client characteristics to understanding treatment process in the therapeutic community?
    Chan KS; Wenzel S; Orlando M; Montagnet C; Mandell W; Becker K; Ebener P
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):871-91. PubMed ID: 15624553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation and retention in drug abuse treatment services research.
    Vaughn T; Sarrazin MV; Saleh SS; Huber DL; Hall JA
    J Subst Abuse Treat; 2002 Dec; 23(4):387-97. PubMed ID: 12495801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.
    Davis AK; Rosenberg H; Rosansky JA
    J Subst Abuse Treat; 2017 Nov; 82():29-33. PubMed ID: 29021112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method for diagnosing and planning the treatment of adolescent drug abusers (the Adolescent Drug Abuse Diagnosis [ADAD] instrument).
    Friedman AS; Utada A
    J Drug Educ; 1989; 19(4):285-312. PubMed ID: 2621537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges.
    Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS
    Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of drug treatments for adolescents in 4 US cities.
    Hser YI; Grella CE; Hubbard RL; Hsieh SC; Fletcher BW; Brown BS; Anglin MD
    Arch Gen Psychiatry; 2001 Jul; 58(7):689-95. PubMed ID: 11448377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug abuse staff and clients smoking together: A shared addiction.
    Guydish J; Le T; Campbell B; Yip D; Ji S; Delucchi K
    J Subst Abuse Treat; 2017 May; 76():64-68. PubMed ID: 28143680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraprofessional versus professional drug abuse counselors: attitudes and expectations of the counselors and their clients.
    LoSciuto L; Aiken LS; Ausetts MA; Brown BS
    Int J Addict; 1984 May; 19(3):233-52. PubMed ID: 6746156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model for evaluating intensive outpatient behavioral health care programs.
    Raskin R; Novacek J; Bahlinger D; Firth L
    Psychiatr Serv; 1996 Nov; 47(11):1227-32. PubMed ID: 8916241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Admission variables as predictors of completion in an adolescent residential drug treatment program.
    Vourakis C
    J Child Adolesc Psychiatr Nurs; 2005; 18(4):161-70. PubMed ID: 16236098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.